Skip to main content
. 2018 Nov 8;8:16584. doi: 10.1038/s41598-018-35027-w

Figure 1.

Figure 1

Experimental design. Scheme (a) indicates the timing of the rotarod training and test, and the duration of the continuous spinal infusion of AMPA and TTC (grey horizontal bars). Black thin arrows indicate the timing of TTC i.m. injections before (TTC i.m. pre-treatment) or after (TTC i.m. post-treatment) surgery. The TrkA blocker GW-441756 was injected i.m. at the same time of TTC (co-administration, white arrows) or before TTC (pre- administration, blue arrows). All i.m. treatments were made bilaterally in both the gastrocnemius (G) and biceps femoris (BF) muscles shown in (b), as related to the infused (pink) and rostral (blue) regions of the spinal cord. These regions are intensively injured by AMPA and were analyzed separately by histology (Fig. 3b). The black dot represents the position of the probe in the spinal cord.